Cannabidiol Treatment Results in a Common Gene Expression Response Across Aggressive Cancer Cells from Various Origins

Background: We previously reported that cannabidiol (CBD), a cannabinoid with a low toxicity profile, downregulated the expression of the prometastatic gene inhibitor of DNA binding 1 (ID1) in cancer cells, leading to inhibition of tumor progression in vivo. While CBD is broadly used, including in t...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cannabis Cannabinoid Res
Main Authors: Desprez, Pierre-Yves, Murase, Ryuichi, Limbad, Chandani, Woo, Rinette W.L., Adrados, Isabel, Weitenthaler, Klemens, Soroceanu, Liliana, Salomonis, Nathan, McAllister, Sean D.
Formato: Artigo
Idioma:Inglês
Publicado: Mary Ann Liebert, Inc., publishers 2021
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8064952/
https://ncbi.nlm.nih.gov/pubmed/33912679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/can.2019.0081
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares